Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1
about
sameAs
The growth-promoting activity of the Bad protein in chicken embryo fibroblasts requires binding to protein 14-3-3Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expressionA novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5Targeted therapy for hepatocellular carcinoma: novel agents on the horizonCore protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virusGenetic Clustering of Hepatitis C Virus Strains and Severity of Recurrent Hepatitis after Liver TransplantationComparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb PathwayEvaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.Phosphorylation status of the parvovirus minute virus of mice particle: mapping and biological relevance of the major phosphorylation sites.Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.Viral hepatocarcinogenesis.Hepatitis C virus biology.Oncogenic potential of hepatitis C virus proteinsPathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinomaActivation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.Hepatitis C virus-induced hepatocellular carcinomaAmino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.Intentional delay of human hepatocarcinogenesis due to suppression of chronic hepatitis.Host cell targets in HCV therapy: novel strategy or proven practice?Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategiesVirus-derived small RNAs in the penaeid shrimp Fenneropenaeus chinensis during acute infection of the DNA virus WSSV14-3-3s are potential biomarkers for HIV-related neurodegeneration.Viral and Cellular Components of AAV2 Replication Compartments.Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib.Emerging MEK inhibitors.Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies.Proteomic alteration of PK-15 cells after infection by porcine circovirus type 2.The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity.Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15.Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.Latent protein LANA2 from Kaposi's sarcoma-associated herpesvirus interacts with 14-3-3 proteins and inhibits FOXO3a transcription factor.Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein.Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression.Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein.Interaction network of tobacco etch potyvirus NIa protein with the host proteome during infectionSustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein.Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein.
P2860
Q24291620-5F5F443F-CBE7-4025-9450-C5E7A67E14ADQ24606745-7D386662-E020-478F-B46A-6BF58428A004Q24676848-2C0CF684-2F7B-4037-AD63-EF95BF5FF43EQ27002288-769262FD-8C9D-4801-8007-31FB9EAB25EBQ27469759-721AC3E4-9B8A-4CE9-9222-AAEA5BEF6AE9Q27469882-8F10DC9A-1107-4E6A-844F-346C18C32B53Q27472753-42B64218-D0FB-432B-B0F7-4845CAC418E5Q27490465-5A3C4F60-77E2-47C1-83C2-279838435952Q33288665-881D8353-4733-40D8-A051-ACF187380F96Q33826365-9AC5C6FD-732B-48AD-BA9C-D2E14E5F2FA4Q33904328-B3B4D6B7-1712-46E4-94A8-41C6633D4899Q34617749-A989A44E-39A0-4CE1-8FD3-6D341888C6E0Q35091465-969581AF-FE6F-4416-B5DC-F6F1CD867D49Q35261292-D452E5CA-AEAF-42ED-A1EE-1DCF029679F2Q35619104-BDAA52BE-CC4F-4804-A07A-07159DBA9F3FQ35631309-81AFA802-7222-4123-BC89-35040F47F941Q35689692-01EC7925-7D2E-4F1C-BABF-E13AC050EDFFQ35787179-F5EFEE61-26B7-49E2-A26A-A883E591CB89Q35824057-AD322AE7-7E0E-4AFA-9A83-CA44CADAD801Q36056232-DD011772-1AF0-417D-8F08-4FA25A29D930Q36077741-EC96ADC6-2A6D-42A3-BBAB-28F813C61A82Q36124729-906E1E7A-6C71-4DAA-8134-12B56DC23E30Q36561567-8792E309-ACB5-4B8C-8C88-15FDAD6A5217Q37044417-6F79BA10-91C6-4D9A-AE63-FF2E907D1E1EQ37149637-EDC37A7E-B097-4BC9-AE32-17A53907D3B2Q37294482-E3E902AD-8BFC-4C47-9133-07048210E352Q37578600-F5D473AA-9247-4B82-BAF3-8EB0BA2F5B22Q37691441-808CE5FA-833A-49B7-8859-38997784194AQ37933157-0F335927-C9DE-451D-BE77-A0ACD235AC3CQ38967958-31EBB20B-1DB6-478A-9A7C-DC843DAE0DE2Q39346072-51191211-681B-4B78-BAED-0478C4F5B9CDQ39510465-38834580-3C93-490E-B888-23198CF9E99AQ39844023-2A80C22C-97EB-4E79-82D5-7078569F849CQ40208122-38E32BD6-491B-4D91-A9C2-80A5E903272EQ40589165-092433F4-1C39-41C5-9BC7-0DB50F486C7EQ40601333-EF1481FE-59AA-4D4B-B4D1-756BB5D5E3E9Q40664486-2BCAD102-6371-4A36-80FE-AF839120D2CBQ40810687-F83C846D-90AA-4D15-A155-3D7207D129A5Q42506244-A5434B16-200F-4947-9354-6358998AE864Q43035847-6853D421-01A4-4D17-A9C7-0A4DCD7F048E
P2860
Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@ast
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@en
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@en-gb
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@nl
type
label
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@ast
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@en
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@en-gb
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@nl
prefLabel
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@ast
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@en
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@en-gb
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@nl
P2093
P2860
P921
P3181
P1433
P1476
Hepatitis C virus core protein ...... and activates the kinase Raf-1
@en
P2093
P2860
P304
P3181
P356
10.1128/JVI.74.4.1736-1741.2000
P407
P577
2000-02-01T00:00:00Z